Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 4
2003 1
2004 1
2006 2
2007 2
2008 3
2009 4
2010 2
2011 2
2012 4
2013 6
2014 1
2015 1
2017 1
2019 2
2021 2
2022 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
IMWG consensus on risk stratification in multiple myeloma.
Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, Miguel JS, Sonneveld P, Cavo M, Usmani S, Durie BG, Avet-Loiseau H; International Myeloma Working Group. Chng WJ, et al. Leukemia. 2014 Feb;28(2):269-77. doi: 10.1038/leu.2013.247. Epub 2013 Aug 26. Leukemia. 2014. PMID: 23974982 Review.
Continuous treatment in multiple myeloma: the future?
Vande Broek I, Jacobs P. Vande Broek I, et al. Transfus Apher Sci. 2013 Oct;49(2):147-50. doi: 10.1016/j.transci.2013.07.017. Epub 2013 Sep 24. Transfus Apher Sci. 2013. PMID: 24074557 Review.
Multiple myeloma--an update on diagnosis and treatment.
Caers J, Vande broek I, De Raeve H, Michaux L, Trullemans F, Schots R, Van Camp B, Vanderkerken K. Caers J, et al. Among authors: vande broek i. Eur J Haematol. 2008 Nov;81(5):329-43. doi: 10.1111/j.1600-0609.2008.01127.x. Epub 2008 Sep 13. Eur J Haematol. 2008. PMID: 18637123 Review.
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.
Delforge M, Vekemans MC, Depaus J, Meuleman N, Van de Velde A, Vande Broek I, Vandervennet S, Van Hoorenbeeck S, Moorkens E, Strens D, Diels J, Ghilotti F, Haefliger B, Dalhuisen S, Deraedt W, Anguille S. Delforge M, et al. Among authors: vande broek i. Hemasphere. 2022 Nov 29;6(12):e813. doi: 10.1097/HS9.0000000000000813. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36479545 Free PMC article. No abstract available.
Extravasation and homing mechanisms in multiple myeloma.
Vande Broek I, Vanderkerken K, Van Camp B, Van Riet I. Vande Broek I, et al. Clin Exp Metastasis. 2008;25(4):325-34. doi: 10.1007/s10585-007-9108-4. Epub 2007 Oct 19. Clin Exp Metastasis. 2008. PMID: 17952614 Review.
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
Fernández de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH, Hajek R, San Miguel JF, Sezer O, Sonneveld P, Kumar SK, Mahindra A, Comenzo R, Palumbo A, Mazumber A, Anderson KC, Richardson PG, Badros AZ, Caers J, Cavo M, LeLeu X, Dimopoulos MA, Chim CS, Schots R, Noeul A, Fantl D, Mellqvist UH, Landgren O, Chanan-Khan A, Moreau P, Fonseca R, Merlini G, Lahuerta JJ, Bladé J, Orlowski RZ, Shah JJ; International Myeloma Working Group. Fernández de Larrea C, et al. Leukemia. 2013 Apr;27(4):780-91. doi: 10.1038/leu.2012.336. Epub 2012 Nov 21. Leukemia. 2013. PMID: 23288300 Free PMC article. Review.
Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians.
Caers J, Vekemans MC, Bries G, Beel K, Delrieu V, Deweweire A, Demuynck H, De Prijck B, De Samblanx H, Kentos A, Meuleman N, Mineur P, Offner F, Vande Broek I, Van Droogenbroeck J, Vande Velde A, Wu KL, Delforge M, Schots R, Doyen C; Multiple Myeloma Study Group of the Belgian Hematological Society. Caers J, et al. Among authors: vande broek i. Ann Med. 2013 Sep;45(5-6):413-22. doi: 10.3109/07853890.2013.801562. Epub 2013 Jun 14. Ann Med. 2013. PMID: 23767978 Free article. Review.
Homing of the myeloma cell clone.
Vanderkerken K, Van Camp B, De Greef C, Vande Broek I, Asosingh K, Van Riet I. Vanderkerken K, et al. Among authors: vande broek i. Acta Oncol. 2000;39(7):771-6. doi: 10.1080/028418600750063488. Acta Oncol. 2000. PMID: 11145431
39 results